CRNX
Price
$30.41
Change
-$0.53 (-1.71%)
Updated
Jun 25 closing price
Capitalization
2.85B
43 days until earnings call
VKTX
Price
$28.36
Change
+$1.27 (+4.69%)
Updated
Jun 26, 11:35 AM (EDT)
Capitalization
3.04B
27 days until earnings call
Interact to see
Advertisement

CRNX vs VKTX

Header iconCRNX vs VKTX Comparison
Open Charts CRNX vs VKTXBanner chart's image
Crinetics Pharmaceuticals
Price$30.41
Change-$0.53 (-1.71%)
Volume$557K
Capitalization2.85B
Viking Therapeutics
Price$28.36
Change+$1.27 (+4.69%)
Volume$3.76K
Capitalization3.04B
CRNX vs VKTX Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. VKTX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (CRNX: $30.41 vs. VKTX: $27.09)
Brand notoriety: CRNX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 73% vs. VKTX: 120%
Market capitalization -- CRNX: $2.85B vs. VKTX: $3.04B
CRNX [@Biotechnology] is valued at $2.85B. VKTX’s [@Biotechnology] market capitalization is $3.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 6 bearish.
  • VKTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both CRNX and VKTX are a bad buy in the short-term.

Price Growth

CRNX (@Biotechnology) experienced а -0.30% price change this week, while VKTX (@Biotechnology) price change was +3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.04B) has a higher market cap than CRNX($2.85B). VKTX YTD gains are higher at: -32.679 vs. CRNX (-40.524). VKTX has higher annual earnings (EBITDA): -171.93M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. VKTX (852M). VKTX has less debt than CRNX: VKTX (1M) vs CRNX (50.8M). CRNX has higher revenues than VKTX: CRNX (760K) vs VKTX (0).
CRNXVKTXCRNX / VKTX
Capitalization2.85B3.04B94%
EBITDA-373.49M-171.93M217%
Gain YTD-40.524-32.679124%
P/E RatioN/AN/A-
Revenue760K0-
Total Cash1.27B852M150%
Total Debt50.8M1M5,080%
FUNDAMENTALS RATINGS
CRNX vs VKTX: Fundamental Ratings
CRNX
VKTX
OUTLOOK RATING
1..100
5861
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
6776
SMR RATING
1..100
9491
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (41) in the Biotechnology industry is somewhat better than the same rating for CRNX (92) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (67) in the Pharmaceuticals Major industry is in the same range as VKTX (76) in the Biotechnology industry. This means that CRNX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as CRNX (94) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to CRNX’s over the last 12 months.

VKTX's Price Growth Rating (64) in the Biotechnology industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to CRNX’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXVKTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBFAX29.70N/A
N/A
1919 Financial Services A
MAILX20.82N/A
N/A
BlackRock International Instl
VIGAX220.47N/A
N/A
Vanguard Growth Index Admiral
FEIFX32.50N/A
N/A
Franklin Equity Income Adv
CTCSX37.79-0.56
-1.46%
Calamos Timpani Small Cap Growth C

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.71%
XNCR - CRNX
58%
Loosely correlated
+3.51%
TRDA - CRNX
57%
Loosely correlated
-0.28%
IDYA - CRNX
56%
Loosely correlated
+1.06%
RVMD - CRNX
55%
Loosely correlated
-4.05%
DYN - CRNX
55%
Loosely correlated
-1.98%
More